Home/Filings/4/0001576427-22-000130
4//SEC Filing

WARNER JAMES 4

Accession 0001576427-22-000130

CIK 0001576427other

Filed

Dec 14, 7:00 PM ET

Accepted

Dec 15, 4:16 PM ET

Size

14.9 KB

Accession

0001576427-22-000130

Insider Transaction Report

Form 4
Period: 2022-12-14
WARNER JAMES
Director
Transactions
  • Sale

    Ordinary Shares

    2022-12-14$25.90/sh20,400$528,36027,553 total
  • Exercise/Conversion

    Non-employee Warrant (right to buy)

    2022-12-1420,4000 total
    Exercise: $10.29Exp: 2023-02-07Ordinary Shares (20,400 underlying)
  • Exercise/Conversion

    Ordinary Shares

    2022-12-14$10.29/sh+10,200$104,95837,753 total
  • Exercise/Conversion

    Non-employee Warrant (right to buy)

    2022-12-1410,2000 total
    Exercise: $10.29Exp: 2023-03-06Ordinary Shares (10,200 underlying)
  • Exercise/Conversion

    Ordinary Shares

    2022-12-14$10.29/sh+20,400$209,91647,953 total
  • Sale

    Ordinary Shares

    2022-12-14$25.90/sh10,200$264,18027,553 total
Footnotes (6)
  • [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
  • [F2]The exercise price of the non-employee warrant is 9.65 euros. The U.S. dollar equivalent of the exercise price is $10.29 using the exchange rate as of December 14, 2022 (1.00 = $1.06587).
  • [F3]For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission.
  • [F4]The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $25.94 to $25.54 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F5]Warrant granted on February 7, 2013. One-fourth of the grant vested on the first anniversary of the grant date and an additional 1/16th of the grant vested quarterly thereafter. Warrant is set to expire on February 7, 2023.
  • [F6]Warrant granted on March 6, 2013. One-fourth of the grant vested on the first anniversary of the grant date and an additional 1/16th of the grant vested quarterly thereafter. Warrant is set to expire on March 6, 2023.

Issuer

Criteo S.A.

CIK 0001576427

Entity typeother

Related Parties

1
  • filerCIK 0001193080

Filing Metadata

Form type
4
Filed
Dec 14, 7:00 PM ET
Accepted
Dec 15, 4:16 PM ET
Size
14.9 KB